These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 15520251

  • 1. Tumor-associated CD75s gangliosides and CD75s-bearing glycoproteins with Neu5Acalpha2-6Galbeta1-4GlcNAc-residues are receptors for the anticancer drug rViscumin.
    Müthing J, Meisen I, Kniep B, Haier J, Senninger N, Neumann U, Langer M, Witthohn K, Milosević J, Peter-Katalinić J.
    FASEB J; 2005 Jan; 19(1):103-5. PubMed ID: 15520251
    [Abstract] [Full Text] [Related]

  • 2. Mistletoe lectin I is a sialic acid-specific lectin with strict preference to gangliosides and glycoproteins with terminal Neu5Ac alpha 2-6Gal beta 1-4GlcNAc residues.
    Müthing J, Meisen I, Bulau P, Langer M, Witthohn K, Lentzen H, Neumann U, Peter-Katalinić J.
    Biochemistry; 2004 Mar 23; 43(11):2996-3007. PubMed ID: 15023051
    [Abstract] [Full Text] [Related]

  • 3. Preferential binding of the anticancer drug rViscumin (recombinant mistletoe lectin) to terminally alpha2-6-sialylated neolacto-series gangliosides.
    Müthing J, Burg M, Möckel B, Langer M, Metelmann-Strupat W, Werner A, Neumann U, Peter-Katalinic J, Eck J.
    Glycobiology; 2002 Aug 23; 12(8):485-97. PubMed ID: 12145189
    [Abstract] [Full Text] [Related]

  • 4. Tumor-associated CD75s- and iso-CD75s-gangliosides are potential targets for adjuvant therapy in pancreatic cancer.
    Distler U, Souady J, Hülsewig M, Drmić-Hofman I, Haier J, Denz A, Grützmann R, Pilarsky C, Senninger N, Dreisewerd K, Berkenkamp S, Schmidt MA, Peter-Katalinic J, Müthing J.
    Mol Cancer Ther; 2008 Aug 23; 7(8):2464-75. PubMed ID: 18723492
    [Abstract] [Full Text] [Related]

  • 5. Differences in CD75s- and iso-CD75s-ganglioside content and altered mRNA expression of sialyltransferases ST6GAL1 and ST3GAL6 in human hepatocellular carcinomas and nontumoral liver tissues.
    Souady J, Hülsewig M, Distler U, Haier J, Denz A, Pilarsky C, Senninger N, Dreisewerd K, Peter-Katalinic J, Müthing J.
    Glycobiology; 2011 May 23; 21(5):584-94. PubMed ID: 21147760
    [Abstract] [Full Text] [Related]

  • 6. The human H3N2 influenza viruses A/Victoria/3/75 and A/Hiroshima/52/2005 preferentially bind to α2-3-sialylated monosialogangliosides with fucosylated poly-N-acetyllactosaminyl chains.
    Meisen I, Dzudzek T, Ehrhardt C, Ludwig S, Mormann M, Rosenbrück R, Lümen R, Kniep B, Karch H, Müthing J.
    Glycobiology; 2012 Aug 23; 22(8):1055-76. PubMed ID: 22534568
    [Abstract] [Full Text] [Related]

  • 7. Discrimination of neolacto-series gangliosides with alpha2-3- and alpha2-6-linked N-acetylneuraminic acid by nanoelectrospray ionization low-energy collision-induced dissociation tandem quadrupole TOF MS.
    Meisen I, Peter-Katalinić J, Müthing J.
    Anal Chem; 2003 Nov 01; 75(21):5719-25. PubMed ID: 14588011
    [Abstract] [Full Text] [Related]

  • 8. Investigation of charge variants of rViscumin by two-dimensional gel electrophoresis and mass spectrometry.
    Lutter P, Meyer HE, Langer M, Witthohn K, Dormeyer W, Sickmann A, Blüggel M.
    Electrophoresis; 2001 Aug 01; 22(14):2888-97. PubMed ID: 11565784
    [Abstract] [Full Text] [Related]

  • 9. Anticancer activity of rViscumin (recombinant mistletoe lectin) in tumor colonization models with immunocompetent mice.
    Schaffrath B, Mengs U, Schwarz T, Hilgers RD, Beuth J, Möckel B, Lentzen H, Gerstmayer B.
    Anticancer Res; 2001 Aug 01; 21(6A):3981-7. PubMed ID: 11911280
    [Abstract] [Full Text] [Related]

  • 10. Cytotoxicity of the novel anti-cancer drug rViscumin depends on HER-2 levels in SKOV-3 cells.
    Abuharbeid S, Apel J, Sander M, Fiedler B, Langer M, Zuzarte ML, Czubayko F, Aigner A.
    Biochem Biophys Res Commun; 2004 Aug 20; 321(2):403-12. PubMed ID: 15358191
    [Abstract] [Full Text] [Related]

  • 11. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
    Pousset D, Piller V, Bureaud N, Monsigny M, Piller F.
    Cancer Res; 1997 Oct 01; 57(19):4249-56. PubMed ID: 9331085
    [Abstract] [Full Text] [Related]

  • 12. Detection of rViscumin in plasma samples by immuno-PCR.
    Adler M, Langer M, Witthohn K, Eck J, Blohm D, Niemeyer CM.
    Biochem Biophys Res Commun; 2003 Jan 17; 300(3):757-63. PubMed ID: 12507515
    [Abstract] [Full Text] [Related]

  • 13. Cytotoxic activity of recombinant bFGF-rViscumin fusion proteins.
    Schmidt A, Möckel B, Eck J, Langer M, Gauert M, Zinke H.
    Biochem Biophys Res Commun; 2000 Oct 22; 277(2):499-506. PubMed ID: 11032750
    [Abstract] [Full Text] [Related]

  • 14. Gangliosides and sialoglycoproteins carrying a rare blood group antigen determinant, Cad, associated with human cancers as detected by specific monoclonal antibodies.
    Hiraiwa N, Tsuyuoka K, Li YT, Tanaka M, Seno T, Okubo Y, Fukuda Y, Imura H, Kannagi R.
    Cancer Res; 1990 Sep 01; 50(17):5497-503. PubMed ID: 2167157
    [Abstract] [Full Text] [Related]

  • 15. Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells.
    Park SY, Yoon SJ, Freire-de-Lima L, Kim JH, Hakomori SI.
    Carbohydr Res; 2009 Aug 17; 344(12):1479-86. PubMed ID: 19559406
    [Abstract] [Full Text] [Related]

  • 16. Role of glycosylation in the anticancer activity of antibacterial peptides against breast cancer cells.
    Han YY, Liu HY, Han DJ, Zong XC, Zhang SQ, Chen YQ.
    Biochem Pharmacol; 2013 Nov 01; 86(9):1254-62. PubMed ID: 23962446
    [Abstract] [Full Text] [Related]

  • 17. Human urinary bladder carcinoma glycoconjugates expressing T-(Gal beta(1-3)GalNAc alpha 1-O-R) and T-like antigens: a comparative study using peanut agglutinin and poly- and monoclonal antibodies.
    Langkilde NC, Wolf H, Clausen H, Orntoft TF.
    Cancer Res; 1992 Sep 15; 52(18):5030-6. PubMed ID: 1516058
    [Abstract] [Full Text] [Related]

  • 18. Complete amino acid sequence of the B chain of mistletoe lectin I.
    Soler MH, Stoeva S, Voelter W.
    Biochem Biophys Res Commun; 1998 May 29; 246(3):596-601. PubMed ID: 9618256
    [Abstract] [Full Text] [Related]

  • 19. Natural Antibodies Against Sialoglycans.
    Shilova N, Huflejt ME, Vuskovic M, Obukhova P, Navakouski M, Khasbiullina N, Pazynina G, Galanina O, Bazhenov A, Bovin N.
    Top Curr Chem; 2015 May 29; 366():169-81. PubMed ID: 24037491
    [Abstract] [Full Text] [Related]

  • 20. Selective detection of terminally alpha 2-3 and alpha 2-6 sialylated neolacto-series gangliosides by immunostaining on thin layer chromatograms.
    Müthing J, Neumann U.
    Biomed Chromatogr; 1993 May 29; 7(3):158-61. PubMed ID: 8318834
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.